Clever Leaves Cannabis Company Exits NASDAQ Amid Financial Strains, Stock Plunges -60%, Investors Impacted
Clever Leaves Cannabis Company Exits NASDAQ Amid Financial Strains, Stock Plunges -60%, Investors Impacted
Once a Cannabis Pioneer, Clever Leaves Holdings Inc. (NASDAQ:CLVR) has announced its plan to voluntarily delist from NASDAQ and deregister its securities.
曾經是大麻先驅的Clever Leaves Holdings Inc.(納斯達克股票代碼:CLVR)宣佈計劃自願從納斯達克退市並註銷其證券。
This financial move, approved by its Board of Directors, aims to terminate and suspend its reporting obligations to the Securities and Exchange Commission (SEC).
這項財務舉措已獲得其董事會的批准,旨在終止和暫停其對證券交易委員會(SEC)的報告義務。
Out By May
五月前推出
Set to initiate the delisting process by filing a Form 25 with the SEC around May 6, Clever Leaves expects the final trading day of its securities on NASDAQ to be approximately May 16. Subsequently, the company will file a Form 15 to cease its reporting duties. This filing, effective 90 days post-submission, will end the company's obligation to submit various SEC reports and forms, including Forms 10-K, 10-Q, and 8-K.
Clever Leaves定於5月6日左右向美國證券交易委員會提交25號表格,啓動退市程序,預計其在納斯達克證券的最後交易日約爲5月16日。隨後,該公司將提交表格15以終止其申報義務。該文件在提交後90天生效,將終止公司提交美國證券交易委員會各種報告和表格的義務,包括10-K、10-Q和8-K表格。
Impact on Investors
對投資者的影響
Investors holding shares or warrants of Clever Leaves should be aware that following the delisting, these securities will no longer trade on NASDAQ. While the securities can still be held, they may be traded over-the-counter (OTC), typically resulting in lower trading volumes and potentially less liquidity. Investors are advised to consult with their financial advisors to better understand the implications of the delisting on their investments and consider their options regarding holding or disposing of their shares.
持有Clever Leaves股票或認股權證的投資者應注意,退市後,這些證券將不再在納斯達克交易。儘管仍可以持有證券,但它們可以在場外交易(OTC),這通常會導致交易量減少和流動性可能降低。建議投資者諮詢財務顧問,以更好地了解退市對其投資的影響,並考慮持有或處置股票的選擇。
Learn more about cannabis stocks, grow your cannabis business and raise capital at Benzinga's New Jersey Market Spotlight on June 17. Network with key industry players, hear from the top operators and close deals that will shape the future. Act now— spots are filling fast. Get your tickets here.
6月17日,在Benzinga的《新澤西市場聚焦》上,了解有關大麻股票的更多信息,發展您的大麻業務並籌集資金。與主要行業參與者建立聯繫,聽取頂級運營商的意見,達成將塑造未來的交易。立即行動——空位很快就填滿了。在這裏獲取門票。
Share Value Is Plunging
股票價值暴跌
Once a major player in the medicinal cannabis industry, Clever Leaves has significantly impacted the sector, employing 296 full-time staff, primarily in Colombia. However, the company's share value has plummeted over 60% since the delisting announcement. At its peak in August 2021, amid the cannabis gold-rush, shares traded at an all-time high of $538, but the current share price has dramatically fallen to around $1.5
Clever Leaves曾經是藥用大麻行業的主要參與者,對該行業產生了重大影響,僱用了296名全職員工,主要分佈在哥倫比亞。但是,自退市公告以來,該公司的股票價值暴跌了60%以上。在2021年8月的頂峯期,在大麻淘金熱中,股票交易價格創下538美元的歷史新高,但目前的股價已急劇跌至1.5美元左右
A Broader Restructuring Plan
更廣泛的重組計劃
In their 2023 annual overview, Clever Leaves reported a revenue increase of 6%, achieving $17.4 million up from $16.4 million The growth was particularly strong in cannabinoid sales, which surged 39% to $6.6 million. The company also enhanced its operational efficiency by optimizing its cost structure, resulting in a 24% reduction in general and administrative expenses.
Clever Leaves在其2023年年度概覽中報告收入增長了6%,從1,640萬美元增長了1,740萬美元。大麻素銷售的增長尤其強勁,激增了39%,至660萬美元。該公司還通過優化成本結構提高了運營效率,使一般和管理費用減少了24%。
The last financial report makes this new decision appear as a move inside a wider restructuring plan. These sorts of cut-cost decisions have been normal in the cannabis space, amid a general and global recession and consolidation, driven by falls in CBD prices and the slowdown of regulatory change.
上一份財務報告顯示,這一新決定似乎是更廣泛的重組計劃中的一項舉措。在CBD價格下跌和監管變革放緩的推動下,在普遍和全球的衰退和整合中,這種削減成本的決定在大麻領域是正常的。
The decision stems from a thorough review of internal strategies and external conditions, influenced by factors such as ongoing non-compliance with Nasdaq's listing requirements and the financial burden of regulatory compliance. By delisting, Clever Leaves says it aims to reduce significant operational costs associated with the demands of public trading and reporting.
該決定源於對內部戰略和外部條件的全面審查,受持續不遵守納斯達克上市要求和監管合規的財務負擔等因素的影響。Clever Leaves表示,通過退市,其目標是降低與公開交易和報告需求相關的大量運營成本。